DLH Holdings Corp.

NCM: DLHC
Live Quote

📈 ZcoreAI Score

Our AI model analyzes DLH Holdings Corp.'s price action across multiple timeframes using regression channels and statistical scoring.

Get DLHC Z-Score →

About DLH Holdings Corp.

Industrials Specialty Business Services
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), Defense Health Agency (DHA), US Army Medical Research and Development Command (MRDC), and US Navy. The company also provides science research and development services and solutions, such as data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions, including NIH and the Center for Disease Control and Prevention, as well as the Military Health System. In addition, it offers systems engineering and integration solutions in the areas of command, control, communications, computers, cyber, intelligence, surveillance, and reconnaissance (C5ISR); modeling, simulation and training, performance-based logistics, and system modernization; and technology-powered health solutions and software engineering on behalf of the US Navy, HHS, VA, and other federal customers. Further, the company holds the trademark, Infinibyte, for cloud-based solution. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.

📊 Fundamental Analysis

DLH Holdings Corp. demonstrates a profit margin of -0.3%, which is below the sector average, suggesting competitive pressure.

The company recently reported -24.1% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -1.0%, which indicates that capital utilization is currently under pressure.

At a current price of $6.15, DLHC currently sits at the 64th percentile of its 52-week range (Range: $2.72 - $8.10).

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
🔴 Beta (Risk) High Volatility

Key Financials

Market Cap
$89.13M
Trailing P/E
--
Forward P/E
-21.96
Beta (5Y)
1.58
52W High
$8.10
52W Low
$2.72
Avg Volume
10K
Day High
Day Low
Get DLHC Z-Score on Dashboard 🚀